Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Carbamazepine Gel Formulation as a Sustained Release Epilepsy Medication for Pediatric Use

Open access

Abstract

This study aimed to develop a carbamazepine (CBZ) sustained release formulation suitable for pediatric use with a lower risk of precipitation. The CBZ was first prepared as sustained release microparticles, and then the microparticles were embedded in alginate beads, and finally, the beads were suspended in a gel vehicle. The microparticles were prepared by a solvent evaporation method utilizing ethyl cellulose as a sustained release polymer and were evaluated for particle size, encapsulation efficiency, and release profile. The beads were fabricated by the dropwise addition of sodium alginate in calcium chloride solution and characterized for size, shape, and release properties. The gel was prepared using iota carrageenan as the gelling agent and evaluated for appearance, syneresis, drug content uniformity, rheology, release profile, and stability. The microparticles exhibited a particle size of 135.01 ± 0.61 µm with a monodisperse distribution and an encapsulation efficiency of 83.89 ± 3.98%. The beads were monodispersed with an average size of 1.4 ± 0.05 mm and a sphericity factor of less than 0.05. The gel was prepared using a 1:1 ratio (gel vehicle to beads) and exhibited no syneresis, good homogeneity, and good shear-thinning properties. The release profile from the beads and from the gel was not significantly affected, maintaining similarity to the tablet form. The gel properties were maintained for one month real time stability, but the accelerated stability showed reduced viscosity and pH with time. In conclusion, CBZ in a gel sustained release dosage form combines the advantages of the suspension form in terms of dosing flexibility, and the advantages of the tablet form in regards to the sustained release profile. This dosage form should be further investigated in vivo in animal models before being considered in clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/pharmaceutics11100488

Cites

Statistics

Figures

Figure 1 CBZ-loaded microparticle characterization. (a) Particle size distribution measured by laser diffraction, (b) morphology of the particles under a light microscope, (c) ATR-FTIR spectra of ethyl cellulose, CBZ and CBZ-loaded microparticles.
Figure 1 CBZ-loaded microparticle characterization. (a) Particle size distribution measured by laser diffraction, (b) morphology of the particles under a light microscope, (c) ATR-FTIR spectra of ethyl cellulose, CBZ and CBZ-loaded microparticles.CC BY · PubMed Central
Figure 2 (a) CBZ-alginate beads, (b) CBZ-gel prepared at a 1:1 ratio of beads to iota carrageenan gel.
Figure 2 (a) CBZ-alginate beads, (b) CBZ-gel prepared at a 1:1 ratio of beads to iota carrageenan gel.CC BY · PubMed Central
Figure 3 Rheology profile of 2.5% w/v iota-carrageenan gel, (a) without CBZ-alginate beads, (b) with CBZ-alginate beads.
Figure 3 Rheology profile of 2.5% w/v iota-carrageenan gel, (a) without CBZ-alginate beads, (b) with CBZ-alginate beads.CC BY · PubMed Central
Figure 4 In vitro CBZ release (mean ± 1.86, n = 3) from CBZ gel in comparison with Tegretol®-XR tablets, CBZ powder, CBZ microparticles, and CBZ beads.
Figure 4 In vitro CBZ release (mean ± 1.86, n = 3) from CBZ gel in comparison with Tegretol®-XR tablets, CBZ powder, CBZ microparticles, and CBZ beads.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 45 · Cited by 38

Research works printed but not linked: 2

  1. Wolters Kluwer Health, A.S.O. H.-S.P. (2018, September 08). Cerner Multum and Micromedex from Truven Health Carbamazepine. Available online: https://www.drugs.com/cdi/carbamazepine.html.
  2. Brinker, C.J., and Scherer, G.W. (2013). Sol-Gel Science: The Physics and Chemistry of Sol-Gel Processing, Academic Press.

Metadata

Authors
Mawazi, S. M., Al-Mahmood, S. M. A., Chatterjee, B., Hadi, H. A., & Doolaanea, A. A.
Affiliations
  • International Islamic University Malaysia (MY)
  • University of Kirkuk (IQ)
  • Narsee Monjee Institute of Management Studies (IN)
Corresponding author
Doolaanea, Abd Almonem
Venue
Pharmaceutics
Publisher
MDPI AG
Published
2019-09-20
Volume
11
Issue
10
Pages
488
ISSN
1999-4923 (ISSN-L)
OpenAlex
W2973333192
Cited by
38
References
45
Citations by year
2026: 3 · 2025: 5 · 2024: 8 · 2023: 7 · 2022: 6 · 2021: 3 · 2020: 6
FWCI
1.59
Type
journal article
Language
en
Open access
Locations
  • Pharmaceutics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • The International Islamic University Malaysia Repository (The International Islamic University Malaysia) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
International Islamic University Malaysia (P-RIGS18-026-0026)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
Keywords
carbamazepine, sustained-release formulation, alginate beads, ethyl cellulose, solvent evaporation, encapsulation efficiency, drug release profile, gel rheology, syneresis, drug stability, antiepileptic drugs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Carbamazepine Gel Formulation as a Sustained Release Epilepsy Medication for Pediatric Use. https://app.cochat.ai/papers/10.3390/pharmaceutics11100488
The paper
Mawazi, S. M., Al-Mahmood, S. M. A., Chatterjee, B., Hadi, H. A., & Doolaanea, A. A. (2019). Carbamazepine Gel Formulation as a Sustained Release Epilepsy Medication for Pediatric Use. Pharmaceutics. https://doi.org/10.3390/pharmaceutics11100488

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.